CSI Market
Sign In | Register

Briacell Therapeutics (BCTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BCTX Annual Balance Sheets →
The data below summarizes Briacell Therapeutics's balance sheet position from Jul 31 2025 to Jul 31 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BCTX/balance-sheets
https://api.csimarket.com/api/v1/companies/BCTX/fundamentals
https://api.csimarket.com/api/v1/companies/BCTX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Jul 31 2026)
(Apr 30 2026) (Jan 31 2026) (Oct 31 2025) (Jul 31 2025)
Assets
Cash & cash equivalent9.85
Short-term Investments, Total10.69
Cash & Short-term Investments19.00
Other Receivables1.12
Other Current Assets0.00
Prepaid Expense, Current AS0.81
Total Current Assets22.04
Equipment/Property/Plant Net0.32
Intangible Assets0.17
Tax Assets, Noncurrent0.31
Prepaid Expense, Noncurrent, Total PR0.32
Other Assets, Noncurrent0.42
Accounts Receivable And Prepaid Expenses Current2.59
Equity Securities F V N I Noncurrent0.75
Total Assets23.58
Liabilities
Accounts Payable7.98
Other Liabilities, Current0.00
Total Current Liabilities7.98
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.04
Accrued Income Taxes, Noncurrent0.31
Total Liabilities8.02
Stockholders' Equity
Warrant Reserve30.22
Sharebased Payment Reserve11.20
Common Stock Value120.91
Retained Earnings / Accumulated Deficit-146.66
Accumulated Other Comprehensive Income-0.14
Other Equity-0.14
Common Stockholder's Equity16.40
Non-controlling interests & other-0.84
Total Stockholder's Equity15.56
Liabilities & Stockholder's Equity23.58
4 historic quarters locked

Sign in to unlock the full Briacell Therapeutics balance sheet history.

Sign In Create Free Account

About Briacell Therapeutics Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260430)
  • Filed with the SEC: June 9, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-027928

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI